The topic in Something to Think About is “Are Drug Prices too High?” The political furor over drug prices that kicked off a year ago over the Hepatitis C cure, Sovaldi, has moved on to therapies for more diseases. Now Hillary Clinton, Bernie Sanders and other politicians are proposing government remedies, including price controls.
The controversy has gone beyond new drugs to include generics. Do we need price controls? Will government regulations slow new pharmaceutical innovations and research? Are the price increases for some generic drugs justified?
